Survival Validation and Gene Mutations of N Descriptors in the Ninth Edition of the TNM Classification for Lung Cancer
NCT06349252 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1263
Last updated 2024-04-05
Summary
The International Association for the Study of Lung Cancer Staging Committee recently unveiled the ninth edition of TNM staging system for lung cancer. This study aims to explore survival outcomes, stage grouping, and gene mutations in N descriptors of this new classification system.
Conditions
Interventions
- PROCEDURE
-
Radical resection
Patients should undergo radical resection.
Sponsors & Collaborators
-
Fudan University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-01
- Primary Completion
- 2024-08-01
- Completion
- 2025-01-01
Countries
- China
Study Locations
More Related Trials
-
Identify Prognostic Biomarkers of Lung Cancer
NCT05010330 ·Status: UNKNOWN
-
Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes
NCT06699979 ·Status: RECRUITING
-
A Radiomic Model for Risk of Local Recurrence and DFS for T3 and T4 Non-small Cell Lung Cancer
NCT06405815 ·Status: COMPLETED
-
A Study of Lymph Node Metastatic Pattern Based Incorporating Tumor Location, GGO Components and Size for Non-small Cell Lung Cancer
NCT06161935 ·Status: COMPLETED
-
Development and Validation of Nomogram Predicting Survival in Chinese SCLC Patients
NCT05673798 ·Status: COMPLETED
-
Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization Associated With Chinese Patients With Advanced Lung Cancer
NCT03505515 ·Status: COMPLETED
-
Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment
NCT06534489 ·Status: RECRUITING
-
SERS-Based Serum Molecular Spectral Screening for Lung Cancer Type
NCT06775002 ·Status: NOT_YET_RECRUITING
-
A Real-World Study of Treatment Patterns and Effectiveness in MET Mutation-Positive Advanced Lung Cancer
NCT06183762 ·Status: RECRUITING
-
Multiomics Tumor Evolution Model of NSCLC
NCT05352035 ·Status: RECRUITING
-
Heterogeneity of Tertiary Lymphoid Structures Predicts Distinct Malignancy and Immune Microenvironment in Prostate Cancer: a Retrospective Cohort Study
NCT06484127 ·Status: COMPLETED
-
A Real-world Study to Explore Recurrence/Metastases of the NSCLC Patients and the Impact Factors of Patient Survivals
NCT03710616 ·Status: UNKNOWN
-
The Establishment and Clinical Application of a Prediction Model of Lung Cancer Distant Metastasis Based on the Genomic Characteristics of Circulating Tumor Cells
NCT04568720 ·Status: UNKNOWN
-
Neoadjuvant Immunochemotherapy for Lung Cancer
NCT06023797 ·Status: COMPLETED
-
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China
NCT03059641 ·Status: COMPLETED
-
Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer
NCT05965024 ·Status: RECRUITING
-
A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC
NCT06443684 ·Status: RECRUITING
-
Precision Diagnosis for Intraoperative Frozen Section of Early Stage Lung Cancer
NCT02941003 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Circulating Tumor DNA and Tumor Tissue DNA by Targeted Sequencing in Non-Small Cell Lung Cancer
NCT02645318 ·Status: COMPLETED
-
DNA Methylation Biomarkers to Predict Survival After Surgery for Lung Adenocarcinoma
NCT06477211 ·Status: COMPLETED
-
Imaging-based Deep Learning for Lung Cancer Diagnosis and Staging
NCT04000620 ·Status: UNKNOWN
-
Prognostic Significance of the Uncertain Resection in NSCLC
NCT06511661 ·Status: ACTIVE_NOT_RECRUITING
-
A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments
NCT06617390 ·Status: COMPLETED
-
Next-generation Sequencing of Small Cell Lung Cancer to Identify Susceptibility Gene and to Assess Treatment
NCT03244904 ·Status: UNKNOWN
-
Study of the Correlation of Tumor Tissue Microbiome to the Pathogenesis of Lung Cancer
NCT04260295 ·Status: UNKNOWN